| |
| |
| Catalent Oral Solid Dose Manufacturing Proven Expertise. Flexible Solutions. Right Scale. |
|
|
| With our integrated development, clinical supply, and manufacturing capabilities, Catalent has a proven track record in successful technology transfers and new product introductions. By combining specialized expertise, flexible solutions, expanded potent handling capabilities and a global network of state-of-the-art facilities, Catalent can help deliver successful treatments to market and to patients, faster. |
|
|
| |
| |
| Join us During DCAT Week March 18-21, 2024 | New York City |
|
|
| Meet with the Catalent team at DCAT Week taking place in New York City from March 18-21, 2024, to learn more about our end-to-end solutions for oral solid dose. We look forward to seeing you there! |
|
|
| |
| Webinar - Developing and Manufacturing Minitablets to Extend Drug Lifecycle |
|
|
| Watch our latest webinar on-demand and learn from industry experts as they navigate the intricate journey of drug development, exploring how minitablets have redefined formulation strategies, efficacy, and patient-centric solutions as well as options for lifecycle management. |
|
|
| |
| eBook - Optimizing Highly Potent API Drug Development and Manufacturing |
|
|
| This eBook explores the challenges and strategies involved in developing and manufacturing HPAPIs as well as highlights the benefits of partnering with an experienced CDMO that can effectively address the challenges of manufacturing potent drugs and support the successful delivery of safe and effective treatments to patients. |
|
|
| Download Now | | | | Article - Modern Modelling Tools for Small Molecule Solid Dose Manufacturing |
|
|
| Rising costs, evolving regulations, and technological advancements are all impacting the manufacture of pharmaceutical oral solid dosage forms. This article discusses current trends for oral solid dose manufacturing and references real-world case studies to examine how mathematical and computerized modelling tools can improve scale-up and efficiency. |
|
|
| |
| | | Every molecule has a challenge. We have a solution.
|
|
|
